NOVARTIS (CQAW039A2315)

By June 19, 2019 Ongoing/In Follow Up

A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma

Leave a Reply